3993-3527 Screening compound: N-(4-methylphenyl)-2-(pyridin-3-yl)quinazolin-4-amine

3993-3527 Screening compound: N-(4-methylphenyl)-2-(pyridin-3-yl)quinazolin-4-amine
3993-3527 Screening compound: N-(4-methylphenyl)-2-(pyridin-3-yl)quinazolin-4-amine alternative view

Chemical Structure Depiction of ChemDiv screening compound 3993-3527
N-(4-methylphenyl)-2-(pyridin-3-yl)quinazolin-4-amine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

3993-3527

Molecular Formula

C20H16N4 (C20 H16 N4)

Compound Name

N-(4-methylphenyl)-2-(pyridin-3-yl)quinazolin-4-amine

IUPAC name

N-(4-methylphenyl)-2-(pyridin-3-yl)quinazolin-4-amine

SMILES

Cc(cc1)ccc1Nc1nc(-c2cnccc2)nc2ccccc12

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

312.37

Hydrogen Bond Acceptors Count

3.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

3.00

Number of Nitrogen and Oxygen Atoms

4

Partition Coefficient, logP

4.963

Distribution Coefficient, logD

4.003

Water Solubility, LogSw

-4.63

Polar Surface Area

37.323

Acid Dissociation Constant (pKa)

19.08

Base Dissociation Constant (pKb)

8.31

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

5.00

3993-3527 in Drug Discovery

Included in Screening Libraries

Anti-Aging Library (44940 compounds)

Antiviral Annotated Library (21441 compounds)

CNS targets activity set (6557 compounds)

SmartTM Library (51161 compounds)

Akt-Targeted Library (14764 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Epigenetics Focused Set (26518 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Metabolic
  • Immune system
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Mechanism of action:
  • Epigenetic
Targets:
  • Kinases
  • Phosphatases

References: we are preparing a list of scientific research reports with 3993-3527 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound 3993-3527?
Check Price and Availability of 3993-3527, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of 3993-3527 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for 3993-3527
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for 3993-3527
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of 3993-3527 available by request